# A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food

> **NCT05347004** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 425809

## Key facts

- **NCT ID:** NCT05347004
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-25
- **Primary completion:** 2022-12-28
- **Final completion:** 2022-12-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05347004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05347004, "A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05347004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*